Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-10-24 | New | $2,376,107 | $2,376,107 | Equity Only | 06b | SEC link |
| 2025-02-21 | New | $2,541 | $2,541 | Equity Only | 06b | SEC link |
| 2024-04-03 | New | $149,987 | $149,987 | Equity Only | 06b | SEC link |
| 2023-02-17 | New | $1,154,071 | $1,154,071 | Equity Only | 06b | SEC link |
| 2022-11-14 | New | $200,000 | $200,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Dana Barnard | Director |
| Steve Buelow | Director |
| Steve Kiziuk | Director |
| Alex Koglin | Director |
| Paul Laur | Director, Executive |
| Bruce Mc Cormick | Director, Executive |
| Kevin Mc Donald | Director |
| Mike Rice | Director |
| Tuck Stibich | Director |
| John Tomes | Director |